Terry Opgenorth

Title: Innovations by Terry Opgenorth in Cancer Vaccine Development

Introduction

Terry Opgenorth is an innovative inventor based in Fort Collins, Colorado. He has made significant contributions to the field of cancer research, particularly in the development of vaccine compositions aimed at combating cancer. His work is characterized by a focus on utilizing inactivated cancer cells to create effective vaccine solutions.

Latest Patents

Terry Opgenorth holds a patent for "Cancer vaccine compositions and methods of use thereof." This patent describes a cancer vaccine composition that includes inactivated cancer cells and an adjuvant. The inactivated cancer cells are specifically designed to be incapable of replication. The patent also outlines a method for producing this cancer vaccine composition, which involves exposing cancer cells to light, such as UV light, in the presence of a photosensitizer like riboflavin.

Career Highlights

Terry Opgenorth is affiliated with the Colorado State University Research Foundation, where he continues to advance his research in cancer vaccine development. His work has the potential to contribute significantly to the field of oncology and improve treatment options for cancer patients.

Collaborations

Terry collaborates with notable colleagues, including Amanda Guth and Raymond Goodrich, who contribute to his research efforts and enhance the impact of his work in the scientific community.

Conclusion

Terry Opgenorth's innovative approach to cancer vaccine development showcases his commitment to advancing medical science. His patent and ongoing research efforts hold promise for improving cancer treatment methodologies.